Authors have retracted a paper from Cell after they were unable to reproduce data in two figures, compromising their confidence in some of the findings.
The authors revisited their experiments after another lab was unable to replicate their data, about proteins that may play a role in lung cancer.
The first author told Nature News in 2013 that the paper may have helped her secure her current position at the Novartis Institutes for Biomedical Research in Massachusetts.
Pulling “Cytohesins are cytoplasmic ErbB receptor activators” appears to be a case of doing the right thing, given the detailed retraction notice:
Continue reading Authors retract non-reproducible Cell paper
If you need evidence of the value of transparency in science, check out a pair of recent corrections in the structural biology literature.






After the reviewer of a rejected paper was publicly outed, the BMJ has taken the unusual step of explaining why it chose not to publish the paper.